A new drug to treat Alzheimer’s disease may soon enter the market, but getting it to patients could be challenging, Bloomberg reports.
Why it matters: The drug, which is called aducanumab and made by Biogen, is the first Alzheimer’s treatment thought to slow the progression of the disease in people who show early signs of cognitive impairment.
Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free
- It could provide a beacon of hope for the millions of Americans who are at risk for the disease, but it’d also present complicated challenges that the health system would have to figure out how to handle.
State of play: The FDA is expected to decide by June 7 whether the drug works well enough to enter the market.
Details: An estimated 88 million Americans 55 and older may be eligible for an initial screening to see if they’re candidates for treatment. Of those, 2.4 million may ultimately qualify, according to a 2017 Rand Corp. analysis.
- The drug is delivered in monthly intravenous infusions, and must be administered to patients early in their disease.
- It’s unclear whether dementia specialists, infusion sites and imaging centers would be able to meet the expected demand, per Bloomberg.
- The RAND analysis found that diagnosis and delivery hurdles could lead to an average wait time of 18 months for a new Alzheimer’s drug like aducanumab.
Additionally, the drug could cost tens of thousands of dollars per year, raising questions about how Medicare and commercial insurers will reimburse for it.
more recommended stories
11-year-old cruise passenger stung by a stingray in Progreso (Watch Video)
An 11-year-old boy, who happened to.
4 out of every 100 young people do not have a job in Yucatan
According to figures provided by Irais.
Daniel Ortega orders the closure of Catholic and Christian radio stations in Nicaragua
After persecuting and censoring the traditional.
One dead after a roof collapsed in Merida’s Itzimná neighborhood
One person was reported dead in.
Senior citizen reported missing was found dead in Texan de Palomeque, Yucatán
A senior citizen reported missing was.
Cuba’s blaze threatens to aggravate the island’s economic crisis
The four-day fire raging at a.
Vehicles and convenience stores set on fire in Central Mexico (Watch Video)
More clashes broke out in central.
Race against time continues in the rescue of 10 Mexican miners after 3 days underground
Large pumps sucked water from a.
Is Colombia about to legalize Cannabis?
Andres Fajardo is the CEO of Clever Leaves.
López Obrador celebrates revocation of injunctions against the Maya Train Project
On Wednesday, August 10th, during his.